Question

A 35-year-old healthy female donor is found to be HBsAg positive during routine blood donation screening. She is asymptomatic with no known liver disease. As part of evaluating her infectious status and risk of disease progression, what is the next best step in her evaluation?

• A. Viral load
• B. IgM levels
• C. Check for Hepatitis D
• D. Anti-HBc IgM

Hint:

Always remember the cardinal virology rule: Hepatitis D cannot exist without Hepatitis B.
Because HDV superinfection leads to the highest risk of cirrhosis and liver cancer among all viral hepatitides, reflex screening for HDV antibodies is now mandatory for every newly diagnosed HBsAg-positive patient.

Answer 1

The Correct Option is C

Concept:
An entirely asymptomatic individual is incidentally discovered to be harboring a chronic Hepatitis B virus infection (indicated by HBsAg positivity) during a routine, mandatory blood bank screening protocol.
The clinical challenge is to identify the single most critical subsequent screening step required by major liver societies to adequately risk-stratify her disease and determine her risk for catastrophic, accelerated progression to liver failure.
Explanation:
• The Hepatitis D Virus (HDV), historically known as the delta agent, is a unique, highly defective single-stranded RNA virus.

• HDV is entirely biologically dependent upon the presence of the Hepatitis B Virus; specifically, it obligately requires the Hepatitis B surface antigen (HBsAg) to form its outer viral envelope, which is necessary for viral replication, cellular entry, and assembly.

• Consequently, an HDV infection can solely occur under two circumstances: either as an acute simultaneous coinfection with HBV, or as a devastating superinfection occurring in a patient who is already a chronic HBsAg carrier.

• Chronic coinfection with both HBV and HDV represents the absolute most severe and aggressive form of chronic viral hepatitis known to medicine.

• Compared to a solitary HBV infection, an HBV/HDV coinfection leads to a massively accelerated clinical progression toward end-stage cirrhosis, a vastly higher rate of hepatocellular carcinoma, and a much higher overall mortality rate.

• Because of these severe clinical implications, and because HDV infection is heavily underdiagnosed globally, current major hepatology guidelines (such as those from AASLD and EASL) issue a very strong, universal recommendation.

• They mandate that absolutely every single individual who is newly diagnosed with HBsAg-positive chronic Hepatitis B must undergo mandatory, routine screening for Hepatitis D (initially via anti-HDV total antibodies) at the time of their initial clinical evaluation.

• While checking the HBV viral load (Option A) and assessing anti-HBc IgM (Option D) are certainly necessary later components of a full HBV workup to determine current replication status and acuity, checking for the presence of Hepatitis D (Option C) is uniquely emphasized as a critical "next best step" in guideline-based risk stratification due to its massive impact on patient survival and treatment choices.
Final Answer:
Guidelines mandate that all patients newly diagnosed with HBsAg-positive chronic Hepatitis B must be universally screened for Hepatitis D to accurately assess their risk for accelerated liver disease.